The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Open accessAbstract
Protein therapeutics hold a prominent and rapidly expanding place among medicinal products. Purified blood products, recombinant cytokines, growth factors, enzyme replacement factors, monoclonal antibodies, fusion proteins, and chimeric fusion proteins are all examples of therapeutic proteins that have been developed in the past few decades and approved for use in the treatment of human disease. Despite early belief that the fully human nature of these proteins would represent a significant advantage, adverse effects associated with immune responses to some biologic therapies have become a topic of some concern. As a result, drug developers are devising strategies to assess immune responses to protein therapeutics during both the preclinical and the clinical phases of development. While there are many factors that contribute to protein immunogenicity, T cell- (thymus-) dependent (Td) responses appear to play a critical role in the development of antibody responses to biologic therapeutics. A range of methodologies to predict and measure Td immune responses to protein drugs has been developed. This review will focus on the Td contribution to immunogenicity, summarizing current approaches for the prediction and measurement of T cell-dependent immune responses to protein biologics, discussing the advantages and limitations of these technologies, and suggesting a practical approach for assessing and mitigating Td immunogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · cited 1×
“), regulation of cell surface markers of activation, signal transduction events, and proliferation [122,123].”
BackgroundInfluence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Standardizing immunophenotyping for the Human Immunology Project
Maecker, H. T., McCoy, J. P., & Nussenblatt, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3158 · Cited by 1,176
Czerkinsky, C. C., Nilsson, L.-Å., Nygren, H., Ouchterlony, Ö., & Tarkowski, A. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90308-3 · Cited by 1,056
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955
Wang, P., Sidney, J., Dow, C., Mothé, B., Sette, A., & Peters, B. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000048 · Cited by 844
Quality by design for biopharmaceuticals
Rathore, A. S., & Winkle, H. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-26 · Cited by 830
Biopharmaceutical benchmarks 2010
Walsh, G. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-917 · Cited by 756
Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M., Gallazzi, F., Protti, M. P., Sinigaglia, F., et al. (1999) · Nature Biotechnology · doi:10.1038/9858 · Cited by 743
Harding, F. A., Stickler, M. M., Razo, J., & DuBridge, R. (2010) · mAbs · doi:10.4161/mabs.2.3.11641 · Cited by 737
Thrombocytopenia caused by the development of antibodies to thrombopoietin
Li, J., Yang, C., Xia, Y., Bertino, A., Glaspy, J., Roberts, M., & Kuter, D. J. (2001) · Blood · doi:10.1182/blood.v98.12.3241 · Cited by 683
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665
How B and T cells talk to each other
Clark, E. A., & Ledbetter, J. A. (1994) · Nature · doi:10.1038/367425a0 · Cited by 641
Mire-Sluis, A. R., Barrett, Y. C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.002 · Cited by 624
Shankar, G., Devanarayan, V., Amaravadi, L., Barrett, Y. C., Bowsher, R., Finco-Kent, D., Fiscella, M., Gorovits, B., Kirschner, S., Moxness, M., et al. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.09.020 · Cited by 613
Molecular Mimicry as a Mechanism of Autoimmune Disease
Cusick, M. F., Libbey, J. E., & Fujinami, R. S. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8294-7 · Cited by 606
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
Bi, L., Lawler, A. M., Antonarakis, S. E., High, K. A., Gearhart, J. D., & Kazazian, H. H. (1995) · Nature Genetics · doi:10.1038/ng0595-119 · Cited by 593
Farrell, R. J., Alsahli, M., Jeen, Y.-T., Falchuk, K. R., Peppercorn, M. A., & Michetti, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50145 · Cited by 550
Immunogenicity of protein therapeutics
De Groot, A. S., & Scott, D. W. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.011 · Cited by 545
Self-citationQuality by Design in Biopharmaceuticals
Yang, H. (2016) · doi:10.1201/9781315371726-7 · Cited by 543
Nielsen, M., & Lund, O. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-296 · Cited by 510
Allergen-responsive CD4+CD25+ Regulatory T Cells in Children who Have Outgrown Cow's Milk Allergy
Karlsson, M. R., Rugtveit, J., & Brandtzaeg, P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032121 · Cited by 506
Czerkinsky, C., Andersson, G., Ekre, H.-P., Nilsson, L.-Å., Klareskog, L., & Ouchterlony, Ö. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90079-8 · Cited by 495
Control systems and decision making for antibody production
Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F., & Brink, R. (2010) · Nature Immunology · doi:10.1038/ni.1900 · Cited by 442
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay
Carson, R. T., & Vignali, D. A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00069-1 · Cited by 402
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”
De Groot, A. S., Moise, L., McMurry, J. A., Wambre, E., Van Overtvelt, L., Moingeon, P., Scott, D. W., & Martin, W. (2008) · Blood · doi:10.1182/blood-2008-02-138073 · Cited by 392
Self-citationImpact of Product-Related Factors on Immunogenicity of Biotherapeutics
Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22276 · Cited by 350 · cited 2×
“factors intrinsic to the final drug product itself that contribute to immunogenicity, may include modifications in the glycosylation profile [18–20], biophysical and biochemical attributes [21–24], or factors introduced during formulation [14,20,25,26].”
BackgroundDimitrov, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-921-1_1 · Cited by 347
Koren, E., Smith, H. W., Shores, E., Shankar, G., Finco-Kent, D., Rup, B., Barrett, Y.-C., Devanarayan, V., Gorovits, B., Gupta, S., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.01.001 · Cited by 328
Classification and Characterization of Therapeutic Antibody Aggregates
Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., & Narhi, L. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160457 · Cited by 316
Sette, A., Buus, S., Appella, E., Smith, J. A., Chesnut, R., Miles, C., Colon, S. M., & Grey, H. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3296 · Cited by 310
Heterologous immunity between viruses
Welsh, R. M., Che, J. W., Brehm, M. A., & Selin, L. K. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00897.x · Cited by 292
Two-step binding mechanism for T-cell receptor recognition of peptide–MHC
Wu, L. C., Tuot, D. S., Lyons, D. S., Garcia, K. C., & Davis, M. M. (2002) · Nature · doi:10.1038/nature00920 · Cited by 280
Greer, G. (1968) · Cited by 279
Brehm, M. A., Cuthbert, A., Yang, C., Miller, D. M., DiIorio, P., Laning, J., Burzenski, L., Gott, B., Foreman, O., Kavirayani, A., et al. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.008 · Cited by 273
Joubert, M. K., Hokom, M., Eakin, C., Zhou, L., Deshpande, M., Baker, M. P., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268
Self-citationThe regulation of allergy and asthma
Umetsu, D. T., & DeKruyff, R. H. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00413.x · Cited by 266
Shankar, G., Pendley, C., & Stein, K. E. (2007) · Nature Biotechnology · doi:10.1038/nbt1303 · Cited by 260
Pathobiology of Secondary Immune Thrombocytopenia
Cines, D. B., Liebman, H., & Stasi, R. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.12.005 · Cited by 246
Beck, A., Wagner-Rousset, E., Bussat, M.-C., Lokteff, M., Klinguer-Hamour, C., Haeuw, J.-F., Goetsch, L., Wurch, T., Dorsselaer, A., & Corvaia, N. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108786786411 · Cited by 246
Gupta, S., Indelicato, S. R., Jethwa, V., Kawabata, T., Kelley, M., Mire-Sluis, A. R., Richards, S. M., Rup, B., Shores, E., Swanson, S. J., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.004 · Cited by 241
Self-citationLazarski, C. A., Chaves, F. A., Jenks, S. A., Wu, S., Richards, K. A., Weaver, J. M., & Sant, A. J. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.009 · Cited by 234
The Th17 family: flexibility follows function
Basu, R., Hatton, R. D., & Weaver, C. T. (2013) · Immunological Reviews · doi:10.1111/imr.12035 · Cited by 229
Flow cytometric measurement of intracellular cytokines
Pala, P., Hussell, T., & Openshaw, P. J. M. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00230-1 · Cited by 222
Steere, A. C., Klitz, W., Drouin, E. E., Falk, B. A., Kwok, W. W., Nepom, G. T., & Baxter-Lowe, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052471 · Cited by 205
Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance
Kendal, A. R., Chen, Y., Regateiro, F. S., Ma, J., Adams, E., Cobbold, S. P., Hori, S., & Waldmann, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110767 · Cited by 199
Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics
De Groot, A. S., & Martin, W. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.01.009 · Cited by 198
Self-citationTricks with tetramers: how to get the most from multimeric peptide–MHC
Wooldridge, L., Lissina, A., Cole, D. K., Van Den Berg, H. A., Price, D. A., & Sewell, A. K. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02848.x · Cited by 184
T cell-independent B cell memory
Defrance, T., Taillardet, M., & Genestier, L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.004 · Cited by 177
From genome to vaccine: in silico predictions, ex vivo verification
De Groot, A. S., Bosma, A., Chinai, N., Frost, J., Jesdale, B. M., Gonzalez, M. A., Martin, W., & Saint-Aubin, C. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00145-1 · Cited by 175
Self-citationHolder, M. J., Wang, H., Milner, A. E., Casamayor, M., Armitage, R. J., Spriggs, M. K., Fanslow, W. C., MacLennan, I. C. M., Gregory, C. D., & Gordon, J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230948 · Cited by 170
Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity
Tangri, S., Mothé, B. R., Eisenbraun, J., Sidney, J., Southwood, S., Briggs, K., Zinckgraf, J., Bilsel, P., Newman, M., Chesnut, R., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3187 · Cited by 169
Shirai, M., Arichi, T., Nishioka, M., Nomura, T., Ikeda, K., Kawanishi, K., Engelhard, V. H., Feinstone, S. M., & Berzofsky, J. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2733 · Cited by 165
Ishioka, G. Y., Fikes, J., Hermanson, G., Livingston, B., Crimi, C., Qin, M., France del Guercio, M., Oseroff, C., Dahlberg, C., Alexander, J., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3915 · Cited by 164
Detection of Intracellular Cytokines by Flow Cytometry
Yin, Y., Mitson‐Salazar, A., & Prussin, C. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im0624s110 · Cited by 162
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
Livingston, B. D., Newman, M. J., Crimi, C., McKinney, D. M., Chesnut, R. W., & Sette, A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00233-x · Cited by 156
An algorithm for the prediction of proteasomal cleavages
Kuttler, C., Nussbaum, A. K., Dick, T. P., Rammensee, H., Schild, H., & Hadeler, K.-P. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3683 · Cited by 155
Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells
Tsuji, N. M., & Kosaka, A. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.09.002 · Cited by 150
Newly discovered roles for basophils: a neglected minority gains new respect
Karasuyama, H., Mukai, K., Tsujimura, Y., & Obata‐Ninomiya, K. (2008) · Nature reviews. Immunology · doi:10.1038/nri2458 · Cited by 147
Taking immunogenicity assessment of therapeutic proteins to the next level
Büttel, I., Chamberlain, P., Chowers, Y., Ehmann, F., Greinacher, A., Jefferis, R., Kramer, D., Kropshofer, H., Lloyd, P. M., Lubiniecki, A. S., et al. (2011) · Biologicals · doi:10.1016/j.biologicals.2011.01.006 · Cited by 145
Self-citationKoren, E., Groot, A. S. D., Jawa, V., Beck, K. D., Boone, T., Rivera, D., Li, L., Mytych, D. T., Koscec, M., Weeraratne, D. K., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.03.544 · Cited by 143
Self-citationReverse ELISPOT assay for clonal analysis of cytokine production
Nordström, I., & Ferruà, B. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90079-9 · Cited by 139
Kong, Y. C., Lomo, L. C., Motte, R. W., Giraldo, A. A., Baisch, J., Strauß, G., Hämmerling, G. J., & David, C. S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1167 · Cited by 137
Elimination of Antibodies to Recombinant Enzyme in Pompe's Disease
Mendelsohn, N. J., Messinger, Y. H., Rosenberg, A. S., & Kishnani, P. S. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0806809 · Cited by 136
Functional and Phenotypic Characterization of the Humanized BLT Mouse Model
Wege, A. K., Melkus, M. W., Denton, P. W., Estes, J. D., & García, J. V. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-75647-7_10 · Cited by 133
Sant, A. J., Chaves, F. A., Jenks, S. A., Richards, K. A., Menges, P. R., Weaver, J. M., & Lazarski, C. A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00307.x · Cited by 131
Pure red-cell aplasia due to anti-erythropoietin antibodies
Eckardt, K., & Casadevall, N. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg182 · Cited by 131
Mouse Models of Bone Marrow Transplantation
Reddy, P. R., Negrin, R. S., & Hill, G. R. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.10.021 · Cited by 130
Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement
Willinger, T., Rongvaux, A., Strowig, T., Manz, M. G., & Flavell, R. A. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.005 · Cited by 128
Godkin, A. J., Smith, K. J., Willis, A., Tejada-Simon, M. V., Zhang, J., Elliott, T. J., & Hill, A. V. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6720 · Cited by 125
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
Cantor, J. R., Yoo, T. H., Dixit, A., Iverson, B. L., Forsthuber, T. G., & Georgiou, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014739108 · Cited by 125
Interrogating the repertoire: broadening the scope of peptide–MHC multimer analysis
Davis, M. M., Altman, J. D., & Newell, E. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3020 · Cited by 124
Honeyman, M. C., Stone, N. L., Falk, B. A., Nepom, G. T., & Harrison, L. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900709 · Cited by 124
Erratum: Standardizing immunophenotyping for the Human Immunology Project
Maecker, H. T., McCoy, J. P., & Nussenblatt, R. B. (2012) · Nature reviews. Immunology · doi:10.1038/nri3229 · Cited by 120
T cell epitope: Friend or Foe? Immunogenicity of biologics in context☆
Weber, C. A., Mehta, P. J., Ardito, M. T., Moise, L., Martin, B., & Groot, A. S. D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.001 · Cited by 114
Discovery and development of biopharmaceuticals: current issues
Strohl, W. R., & Knight, D. M. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.012 · Cited by 111
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
DEGROOT, A., MCMURRY, J., & MOISE, L. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.002 · Cited by 109
Congia, M., Patel, S. D., Cope, A. P., Virgiliis, S. D., & Sønderstrup, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3833 · Cited by 107
Prediction of Immunogenicity of Therapeutic Proteins
Bryson, C. J., Jones, T. D., & Baker, M. (2010) · BioDrugs · doi:10.2165/11318560-000000000-00000 · Cited by 102
A Human Lymph Node In Vitro—Challenges and Progress
Giese, C., Demmler, C. D., Ammer, R., Hartmann, S., Lubitz, A., Miller, L., Müller, R. D., & Marx, U. (2006) · Artificial Organs · doi:10.1111/j.1525-1594.2006.00303.x · Cited by 100
Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity
Barbosa, M. D. F. S., Vielmetter, J., Chu, S. Y., Smith, D. D., & Jacinto, J. M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.017 · Cited by 99
Immunological substance testing on human lymphatic micro-organoids in vitro
Giese, C., Lubitz, A., Demmler, C. D., Reuschel, J., Bergner, K., & Marx, U. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.03.001 · Cited by 95
Groot, A. S. D., Ardito, M. T., McClaine, E. M., Moise, L., & Martin, W. D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.040 · Cited by 93
From genome to vaccine—new immunoinformatics tools for vaccine design
Groot, A. S. D., & Berzofsky, J. A. (2004) · Methods · doi:10.1016/j.ymeth.2004.06.004 · Cited by 93
Wullner, D., Zhou, L., Bramhall, E., Kuck, A. J., Goletz, T. J., Swanson, S. J., Chirmule, N. B., & Jawa, V. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.018 · Cited by 91
Self-citationvan Beers, M. M. C., Jiskoot, W., & Schellekens, H. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0086 · Cited by 86
Le, A. X., Bernhard, E. J., Holterman, M., Strub, S., Parham, P., Lacy, E., & Engelhard, V. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.4.1366 · Cited by 86
CRIM‐negative infantile Pompe disease: 42‐month treatment outcome
Rohrbach, M., Klein, A., Köhli, A., Veraguth, D., Scheer, I., Balmer, C., Lauener, R. P., & Baumgartner, M. R. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9209-0 · Cited by 84
Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes
McMurry, J. A., Sbai, H., Gennaro, M. L., Carter, E. J., Martin, W. D., & Groot, A. S. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2004.09.005 · Cited by 83
Commensal gut flora and brain autoimmunity: a love or hate affair?
Berer, K., & Krishnamoorthy, G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0949-9 · Cited by 82
Yeung, V. P., Chang, J., Miller, J., Barnett, C., Stickler, M. M., & Harding, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6658 · Cited by 81
Moxness, M. S., Tatarewicz, S. M., Weeraratne, D. K., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.053272 · Cited by 81
Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo
Moise, L., Song, C. H., Martin, W. D., Tassone, R., Groot, A. S. D., & Scott, D. W. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.11.010 · Cited by 80
Man, S., Newberg, M. H., Crotzer, V. L., Luckey, C. J., Williams, N. S., Chen, Y., Huczko, E. L., Ridge, J. P., & Engelhard, V. H. (1995) · International Immunology · doi:10.1093/intimm/7.4.597 · Cited by 79
Peptide length-based prediction of peptide–MHC class II binding
Chang, S. T., Ghosh, D., Kirschner, D. E., et al. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl479 · Cited by 78
McMurry, J. A., Gregory, S. H., Moise, L., Rivera, D. S., Buus, S., & Groot, A. S. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.039 · Cited by 78
Development of a DNA-MVA/HIVA vaccine for Kenya
Hanke, T., McMichael, A. J., Mwau, M., Wee, E. G., Ceberej, I., Patel, S. P., Sutton, J., Tomlinson, M., & Samuel, R. V. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00085-3 · Cited by 75
Reipert, B. M., Sasgary, M., Ahmad, R., Turecek, P. L., & Schwarz, H. P. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616733 · Cited by 74
Qu, C., Nguyen, V. A., Mérad, M., & Randolph, G. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801532 · Cited by 71
Clustering Class I MHC Modulates Sensitivity of T Cell Recognition
Fooksman, D., Grönvall, G. K., Tang, Q., & Edidin, M. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6673 · Cited by 71
Optimization of a dendritic cell-based assay for the in vitro priming of naïve human CD4+ T cells
Moser, J. M., Sassano, E. R., Leistritz, D. C., Eatrides, J. M., Phogat, S. K., Koff, W. C., & Drake, D. R. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.11.006 · Cited by 71
Naive and memory B cells in T-cell-dependent and T-independent responses
Zubler, R. H. (2001) · Springer Seminars in Immunopathology · doi:10.1007/s281-001-8167-7 · Cited by 71
De-immunization of therapeutic proteins by T-cell epitope modification.
Groot, A. S. D., Knopp, P. M., & Martin, W. J. (2005) · PubMed · Cited by 70
Kessler, J. H., Mommaas, B., Mutis, T., Huijbers, I. J., Vissers, D. C. J., Benckhuijsen, W. E., Schreuder, G. M. T., Offringa, R., Goulmy, E., Melief, C. J. M., et al. (2003) · Human Immunology · doi:10.1016/s0198-8859(02)00787-5 · Cited by 69
Tatarewicz, S. M., Wei, X. L., Gupta, S., Masterman, D. M., Swanson, S. J., & Moxness, M. S. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9117-8 · Cited by 69
An Immunologic Model for Rapid Vaccine Assessment — A Clinical Trial in a Test Tube
Higbee, R. G., Byers, A. M., Dhir, V., Drake, D., Gappa‐Fahlenkamp, H., Gangur, J., Kachurin, A., Kachurina, O., Leistritz, D. C., Ma, Y., et al. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903701s05 · Cited by 69
Zhang, G., Petrovsky, N., Kwoh, C., August, J. T., & Brusić, V. (2006) · Immunome Research · doi:10.1186/1745-7580-2-3 · Cited by 69
Identification and removal of immunogenicity in therapeutic proteins.
Baker, M., & Jones, T. D. (2007) · PubMed · Cited by 68
Qian, J., Burkly, L. C., Smith, E., Ferrant, J. L., Hoyer, L. W., Scott, D. W., & Haudenschild, C. C. (2000) · European Journal of Immunology · Cited by 68
Doytchinova, I. A., Walshe, V. A., Jones, N., Gloster, S. E., Borrow, P., & Flower, D. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7495 · Cited by 67
Kim, Y., Sette, A., & Peters, B. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.10.010 · Cited by 65
Verthelyi, D. I., & Wang, V. Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015252 · Cited by 65
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays
Justesen, S. F. L., Harndahl, M. N., Lamberth, K., Nielsen, L. B., & Buus, S. (2009) · Immunome Research · doi:10.1186/1745-7580-5-2 · Cited by 64
Autoimmunity in rheumatoid arthritis: different antigens—common principles
Trouw, L. A., Huizinga, T. W. J., & Toes, R. E. M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202349 · Cited by 63
Buchli, R., VanGundy, R. S., Hickman, H. D., Giberson, C. F., Bardet, W., & Hildebrand, W. H. (2005) · Biochemistry · doi:10.1021/bi050255v · Cited by 60
Jaber, A., & Baker, M. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.10.023 · Cited by 59
Long-Term Therapy with Intravenous Immunoglobulin is Beneficial in Patients with Autoimmune Diseases
Zandman‐Goddard, G., Krauthammer, A., Levy, Y. M., Langevitz, P., & Shoenfeld, Y. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8278-7 · Cited by 59
Jordan, S. C., Toyoda, M., & Vo, A. A. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.10 · Cited by 59
Immunogenicity of biotherapeutics in the context of developing biosimilars and biobetters
Barbosa, M. D. F. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.01.011 · Cited by 58
Optimization algorithms for functional deimmunization of therapeutic proteins
Parker, A. S., Zheng, W. H., Griswold, K. E., & Bailey‐Kellogg, C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-180 · Cited by 57
Deimmunization of Monoclonal Antibodies
Jones, T. D., Crompton, L. J., Carr, F. J., & Baker, M. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-554-1_21 · Cited by 56
Schanen, B. C., Groot, A. S. D., Moise, L., Ardito, M. T., McClaine, E. M., Martin, W. D., Wittman, V., Warren, W. L., & Drake, D. R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.019 · Cited by 56
Pan, S., Trejo, T., Hansen, J., Smart, M. K., & David, C. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2925 · Cited by 55
Cousens, L. P., Su, Y. A., McClaine, E. M., Li, X., Terry, F. E., Smith, R. J., Lee, J., Martin, W. D., Scott, D. W., & Groot, A. S. D. (2013) · Journal of Diabetes Research · doi:10.1155/2013/621693 · Cited by 52
Self-citationBond, K. B., Sriwanthana, B., Hodge, T. W., Groot, A. S. D., Mastro, T. D., Young, N. L., Promadej, N., Altman, J. D., Limpakarnjanarat, K., & McNicholl, J. M. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201750236988 · Cited by 52
Garman, R. D., Munroe, K. J., & RICHARDS, S. M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02567.x · Cited by 51
Perry, L., Jones, T. D., & Baker, M. (2008) · Drugs in R&D · doi:10.2165/0126839-200809060-00004 · Cited by 51
Reducing the Immunogenicity of Protein Therapeutics
Onda, M. (2009) · Current Drug Targets · doi:10.2174/138945009787354511 · Cited by 48
Inaba, H., Martin, W. D., Groot, A. S. D., Qin, S., & DeGroot, L. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2537 · Cited by 48
Mueller, R., Karle, A. C., Vogt, A. B., Kropshofer, H., Ross, A., Mäder, K., & Mahler, H. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21672 · Cited by 47
Self-citationWeaver, J. M., Lazarski, C. A., Richards, K. A., Chaves, F. A., Jenks, S. A., Menges, P. R., & Sant, A. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3039 · Cited by 46
Kamaté, C., Lenting, P. J., van den Berg, H. M., & Mutis, T. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02336.x · Cited by 46
Dhir, V., Fort, M. M., Mahmood, A., Higbee, R. G., Warren, W., Narayanan, P. K., & Wittman, V. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2011.613419 · Cited by 45
Induction of Immunological Tolerance/Hyporesponsiveness in Baboons with a Nondepleting CD4 Antibody
Winsor-Hines, D., Merrill, C., O'Mahony, M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4715 · Cited by 45
Stickler, M. M., Valdes, A. M., Gebel, W., Razo, O. J., Faravashi, N., Chin, R., Rochanayon, N., & Harding, F. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364027 · Cited by 43
Of [hamsters] and men: A new perspective on host cell proteins
Gutiérrez, A. H., Moise, L., & Groot, A. S. D. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22378 · Cited by 43
Elimination of a Human T-cell Region in Staphylokinase by T-cell Screening and Computer Modeling
Plaisance, S., Vanderlick, K., Vandervoort, P., Brepoels, K., Collen, D., Maeyer, M. D., & Warmerdam, P. A. M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613064 · Cited by 42
Can we prevent immunogenicity of human protein drugs?
Scott, D. W., & Groot, A. S. D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117564 · Cited by 41
Röhn, T. A., Reitz, A., Paschen, A., Nguyen, X. D., Schadendorf, D., Vogt, A. B., & Kropshofer, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1973 · Cited by 40
Self-citationAntigen Presentation – Recent Developments
Rammensee, H. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237320 · Cited by 39
Su, Y. A., Rossi, R. J., Groot, A. S. D., & Scott, D. W. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912441 · Cited by 38
Ma, Y., Poisson, L., Sánchez‐Schmitz, G., Pawar, S., Qu, C., Randolph, G. J., Warren, W. L., Mishkin, E. M., & Higbee, R. G. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03237.x · Cited by 37
Cohen, T. S. D., Moise, L., Ardito, M. T., Martin, W. D., & Groot, A. S. D. (2010) · BioMed Research International · doi:10.1155/2010/961752 · Cited by 37
CD40: A Pivotal Receptor In the Determination of Life/Death Decisions in B Lymphocytes
Klaus, G. G. B., Choi, M. S. K., Lam, E. W. ‐., et al. (1997) · International Reviews of Immunology · doi:10.3109/08830189709068169 · Cited by 37
Involvement of IL‐2 in homeostasis of regulatory T cells: the IL‐2 cycle
Yarkoni, S., Kaminitz, A., Sagiv, Y., Yaniv, I., & Askenasy, N. (2008) · BioEssays · doi:10.1002/bies.20812 · Cited by 36
Zhang, G., Khan, A. M., Kellathur, S. N., Heiny, A. T., Lee, K. X., Kwoh, C. K., August, J. T., & Brusić, V. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-s1-s19 · Cited by 34
Circumventing immunogenicity in the development of therapeutic antibodies.
Holgate, R., & Baker, M. (2009) · PubMed · Cited by 33
B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses
Pratt, K. P., & Thompson, A. R. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8120-7 · Cited by 33
Flower, D. R., Phadwal, K., Macdonald, I. K., Coveney, P. V., Davies, M. N., & Wan, S. (2010) · Immunome Research · doi:10.1186/1745-7580-6-s2-s4 · Cited by 33
The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309
Praditpornsilpa, K., Kupatawintu, P., Mongkonsritagoon, W., Supasyndh, O., Jootar, S., Intarakumthornchai, T., Pongskul, C., Prasithsirikul, W., Achavanuntakul, B., Ruangkarnchanasetr, P., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn450 · Cited by 33
Predicting MHC-II Binding Affinity Using Multiple Instance Regression
EL‐Manzalawy, Y., Dobbs, D. L., & Honavar, V. (2010) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2010.94 · Cited by 32
Findlay, L., Eastwood, D., Ball, C., Robinson, C. J., Bird, C., Wadhwa, M., Thorpe, S. J., Thorpe, R., Stebbings, R., & Poole, S. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.06.022 · Cited by 31
Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
Jawa, V., Hokom, M. M., Hu, Z., et al. (2010) · Annals of Hematology · doi:10.1007/s00277-010-0908-2 · Cited by 28
Self-citationCompetition‐Based Cellular Peptide Binding Assay for HLA Class I
Kessler, J. H., Benckhuijsen, W. E., Mutis, T., Melief, C. J. M., van der Burg, S. H., & Drijfhout, J. W. (2004) · Current Protocols in Immunology · doi:10.1002/0471142735.im1812s61 · Cited by 27
Strategies for preclinical immunogenicity assessment of protein therapeutics.
Stas, P., & Lasters, I. (2009) · PubMed · Cited by 26
Didierlaurent, A. M., Ramirez, J.-C., Gherardi, M. M., Zimmerli, S. C., Graf, M., Orbea, H. A., Pantaleo, G., Wagner, R., Estéban, M., Kraehenbühl, J.-P., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.025 · Cited by 26
CD4+ T-Cell Epitope Determination Using Unexposed Human Donor Peripheral Blood Mononuclear Cells
Stickler, M. M., Estell, D. A., & Harding, F. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200011000-00006 · Cited by 26
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis
van der Marel, S., Majowicz, A., Kwikkers, K., van Logtenstein, R., Velde, A. A. T., Groot, A. S. D., Meijer, S. L., van Deventer, S. J. H., Petry, H., Hommes, D. W., et al. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i32.4288 · Cited by 24
An In Vitro Human Cell-Based Assay to Rank the Relative Immunogenicity of Proteins
Stickler, M. M., Rochanayon, N., Razo, O. J., Mucha, J., Gebel, W., Faravashi, N., Chin, R., Holmes, S., & Harding, F. A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfh021 · Cited by 24
Charo, J., Sundbäck, M., Geluk, A., Ottenhoff, T. H. M., & Kiessling, R. W. (2001) · Human Gene Therapy · doi:10.1089/104303401750476285 · Cited by 23
Joseph, A. M., Neff, K. S., Richard, J., Gao, L., Bangari, D. S., Joly, M., Culm-Merdek, K., Garman, R. D., Williams, J. M., Richards, S. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103601 · Cited by 20
Modelling the immunogenicity of therapeutic proteins using T cell epitope mapping.
Groot, A. S. D., Rayner, J., & Wj, M. (2003) · PubMed · Cited by 17
In silico characterization of immunogenic epitopes presented by HLA-Cw*0401
Tong, J. C., Zhang, Z. H., August, J. T., Brusić, V., Tan, T. W., & Ranganathan, S. (2007) · Immunome Research · doi:10.1186/1745-7580-3-7 · Cited by 16
Hellendoorn, K., Jones, T., Watkins, J., Baker, M., Hamilton, A., & Carr, F. J. (2004) · Cancer Cell International · doi:10.1186/1475-2867-4-s1-s20 · Cited by 12
Sauerborn, M., van de Vosse, E., Delawi, D., et al. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0075 · Cited by 12
Mangalam, A. K., Rodriguez, M., & David, C. S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.005 · Cited by 11
Cited by
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Immunogenicity of Therapeutic Protein Aggregates
Moussa, E. M., Panchal, J. P., Moorthy, B. S., Blum, J. S., Joubert, M. K., Narhi, L. O., & Topp, E. M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.002 · Cited by 529
Base editing: advances and therapeutic opportunities
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0084-6 · Cited by 476
Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
Krishna, M., & Nadler, S. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00021 · Cited by 389
Metadata
- Authors
- Jawa, V., Cousens, L. P., Awwad, M., Wakshull, E., Kropshofer, H., & De Groot, A. S.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 149
- Issue
- 3
- Pages
- 534-555
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W2114964760
- Cited by
- 270
- References
- 172
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.